Home » Topics » Conferences

Conferences
RSS

Pharmacokinetics of AMP-579 are affected by body weight but not by renal function

March 24, 1999

DuPont presents 4-aminoquinazoline cyclin-dependent kinase inhibitors

March 24, 1999

Allos presents phase Ib results of RSR-13 in patients with angina

March 24, 1999

Dual dopamine D1/D5 antagonist blocks the rewarding effects of cocaine in humans

March 24, 1999

High-affinity RARalpha receptor agonists reported by Eisai at ACS meeting

March 24, 1999

ACS highlights: 3-D progresses in development of new class of thrombin inhibitors

March 24, 1999

Favorable safety and PK/PD profiles reported for CFC-222

March 24, 1999

Kyowa Hakko and Cor select development candidates for inhibiting PDGF receptor phosphorylation

March 24, 1999

Merck's faster acting and more potent formulation relieves headache pain better than ibuprofen

March 23, 1999

NCI scientists evaluate MMP inhibitor from CollaGenex

March 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...